Q32 Bio Inc. (QTTB)

Every figure this model derived for QTTB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 106,270,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 109,646,000 AssetsCurrent 2026-06-30
current liabilities 5,401,000 LiabilitiesCurrent 2026-06-30
equity 105,905,000 StockholdersEquity 2026-06-30
ocf -19,828,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 53,737,000 Revenues 2025-12-31
sbc 5,878,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up QTTB on one particular measure came for.

RatioValue
cash operating margin43.1
current ratio20.3
current ratio reported20.3
deferred revenue growth-100.0
dilution pct27.53
fcf margin-36.9
growth cv2.52
operating margin31.45
owner earnings margin-47.84
sbc pct revenue10.94

What to be careful about

What this model itself distrusts about QTTB's figures. Written by the derivation as it ran, not added afterwards.